Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (2'R) 2' deoxy 2' halo 2' methyluridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106188193A reveals a novel N-protection strategy for Sofosbuvir intermediates, ensuring high purity, reduced impurities, and scalable manufacturing for global supply chains.